Kubota Y, Tanaka T, Irino S
First Department of Internal Medicine, Kagawa Medical School, Japan.
Leuk Res. 1991;15(4):195-204. doi: 10.1016/0145-2126(91)90121-9.
We describe the properties of three monoclonal antibodies (McAbs) (21H73, 37G7 and 49C12) against K562 cell surface antigens correlated with differentiation induced by 12-O-tetradecanoyl phorbol-13-acetate (TPA). Each of the McAbs immunoprecipitated K562 cell surface antigen with molecular weight (MW) of approximately 51 kD, 82 kD or 92 kD, respectively. The antigens detected by McAbs 21H73 and 37G7 were not immunoprecipitated from K562 cells differentiated into monocyte-macrophages by TPA (K562-TPA). On the other hand, 49C12 immunoprecipitated an antigen with MW of 92 kD from K562-TPA cells, but not from undifferentiated K562 cells. To examine the distribution of these antigens among human haematopoietic stem cells, bone marrow cells were separated by the panning method using these McAbs and subjected to colony-forming assays. The McAb 21H73 reacted with CFU-mix and BFU-E but with neither CFU-E nor CFU-GM. CFU-mix and BFU-E were enriched approximately 6.2-14.7-fold and 2-fold by the panning procedure using 21H73, respectively. On the other hand, 37G7 reacted only with BFU-E, and 49C12 reacted with CFU-GM but not with any other haematopoietic progenitor cells. We also examined the reactivity of these McAbs with leukaemia cells freshly isolated from 26 patients. The antigen defined by 21H73 was not expressed on any leukaemia cells from patients except for cells from an acute lymphocytic leukaemia (ALL, L3) and a CML in blastic crisis. The McAb 37G7 reacted with several types of leukaemia cells. The antigen defined by 49C12 was expressed on almost all leukaemia cells isolated from patients. These results suggest that 21H73 allows purification and enrichment of normal haematopoietic pluripotent stem cells from both normal and leukaemia patients' bone marrow specimens, especially following the step to remove leukaemia cells and haematopoietic progenitor cells other than CFU-mix by using 37G7 and/or 49C12.
我们描述了三种针对K562细胞表面抗原的单克隆抗体(McAbs)(21H73、37G7和49C12)的特性,这些抗原与12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)诱导的分化相关。每种McAb分别免疫沉淀分子量(MW)约为51 kD、82 kD或92 kD的K562细胞表面抗原。McAb 21H73和37G7检测到的抗原不能从经TPA分化为单核细胞 - 巨噬细胞的K562细胞(K562 - TPA)中免疫沉淀出来。另一方面,49C12能从K562 - TPA细胞中免疫沉淀出一种分子量为92 kD的抗原,但不能从未分化的K562细胞中免疫沉淀出来。为了检测这些抗原在人类造血干细胞中的分布,使用这些McAbs通过淘选法分离骨髓细胞,并进行集落形成试验。McAb 21H73与CFU - mix和BFU - E反应,但与CFU - E和CFU - GM均无反应。使用21H73进行淘选程序后,CFU - mix和BFU - E分别富集了约6.2 - 14.7倍和2倍。另一方面,37G7仅与BFU - E反应,49C12与CFU - GM反应,但与任何其他造血祖细胞均无反应。我们还检测了这些McAbs与从26例患者新鲜分离的白血病细胞的反应性。除急性淋巴细胞白血病(ALL,L3)和急变期慢性粒细胞白血病(CML)患者的细胞外,21H73所定义的抗原在其他患者的任何白血病细胞上均未表达。McAb 37G7与几种类型的白血病细胞反应。49C12所定义的抗原在从患者分离的几乎所有白血病细胞上均有表达。这些结果表明,21H73能够从正常和白血病患者的骨髓标本中纯化和富集正常造血多能干细胞,特别是在使用37G7和/或49C12去除白血病细胞和除CFU - mix之外的造血祖细胞之后。